Hyperimmune Globulins Market to Hit $3.2 Billion by 2033 - New Report Reveals 6.2% CAGR Surge
Hyperimmune globulins are a specialized form of immunoglobulin therapy derived from plasma donors who have unusually high titers of antibodies directed at a specific antigen or pathogen. These are used for the treatment or mitigation of established infection in high-risk patients. These are derived from donors who either have recovered from infection or have been vaccinated/immunized to generate high titers of desired antibody. The collected plasma is then pooled, fractionated, purified, screened, and formulated to create the final product. Allied Market Research released a report on the hyperimmune globulins industry , which provides industry dynamics, including growth drivers, opportunities, and challenges. This report further offers regional analysis and a competitive landscape of the domain. The sector accounted for $1.7 billion in 2023 and is anticipated to reach $3.2 billion by 2033, growing at a CAGR of 6.2% during the study period. 👉 Download Free PDF (Only For Today) ✔ h...